The Potassium Channel KCa3.1 Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer’s Disease

Abramov, 2003, Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity., J. Neurosci., 23, 5088, 10.1523/JNEUROSCI.23-12-05088.2003

Agulhon, 2012, Calcium signaling and gliotransmission in normal vs. reactive astrocytes., Front. Pharmacol., 3, 10.3389/fphar.2012.00139

Alberdi, 2013, Ca(2+) -dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid beta-treated astrocytes and in a model of Alzheimer’s disease., Aging Cell, 12, 292, 10.1111/acel.12054

Bouhy, 2011, Inhibition of the Ca(2)(+)-dependent K(+) channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury., J. Neurosci., 31, 16298, 10.1523/JNEUROSCI.0047-11.2011

Carter, 2012, Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG., J. Nucl. Med., 53, 37, 10.2967/jnumed.110.087031

Chen, 2016, Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury., Arch. Toxicol., 90, 2249, 10.1007/s00204-015-1607-5

Di, 2010, Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis., Proc. Natl. Acad. Sci. U.S.A., 107, 1541, 10.1073/pnas.0910133107

Ferreira, 2013, Selective activation of KCa3.1 and CRAC channels by P2Y2 receptors promotes Ca(2+) signaling, store refilling and migration of rat microglial cells., PLoS ONE, 8, 10.1371/journal.pone.0062345

Garwood, 2011, Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture., Cell Death Dis., 2, 10.1038/cddis.2011.50

Heneka, 2001, Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease., J. Neuropathol. Exp. Neurol., 60, 906, 10.1093/jnen/60.9.906

Jo, 2014, GABA from reactive astrocytes impairs memory in mouse models of Alzheimer’s disease., Nat. Med., 20, 886, 10.1038/nm.3639

Kaushal, 2007, The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration., J. Neurosci., 27, 234, 10.1523/JNEUROSCI.3593-06.2007

Khakh, 2015, Diversity of astrocyte functions and phenotypes in neural circuits., Nat. Neurosci., 18, 942, 10.1038/nn.4043

Lallet-Daher, 2009, Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry., Oncogene, 28, 1792, 10.1038/onc.2009.25

Maezawa, 2011, Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity., J. Biol. Chem., 286, 3693, 10.1074/jbc.M110.135244

Matos, 2008, Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades., Neuroscience, 156, 898, 10.1016/j.neuroscience.2008.08.022

Mauler, 2004, Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma., Eur. J. Neurosci., 20, 1761, 10.1111/j.1460-9568.2004.03615.x

Morris, 1984, Developments of a water-maze procedure for studying spatial learning in the rat., J. Neurosci. Methods, 11, 47, 10.1016/0165-0270(84)90007-4

O’Callaghan, 2014, Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity., PLoS ONE, 9, 10.1371/journal.pone.0102003

Reich, 2005, Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice., Eur. J. Immunol., 35, 1027, 10.1002/eji.200425954

Reilly, 2003, Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model., Proc. Natl. Acad. Sci. U.S.A., 100, 4837, 10.1073/pnas.0330745100

Rodriguez, 2009, Astroglia in dementia and Alzheimer’s disease., Cell Death. Differ., 16, 378, 10.1038/cdd.2008.172

Rodriguez-Gonzalez, 2016, Neuroprotective effects of dexmedetomidine conditioning strategies: evidences from an in vitro model of cerebral ischemia., Life Sci., 144, 162, 10.1016/j.lfs.2015.12.007

Schöll, 2015, Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography., Sci. Rep., 10, 10.1038/srep16404

Scuderi, 2014, Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease., Cell Death Dis., 5, 10.1038/cddis.2014.376

Sofroniew, 2015, Astrogliosis., Cold Spring Harb. Perspect. Biol., 7, 10.1101/cshperspect.a020420

Szegedi, 2006, Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo., FASEB. J., 20, 1191, 10.1096/fj.05-4891fje

Toyama, 2008, The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans., J. Clin. Invest., 118, 3025, 10.1172/JCI30836

Tuppo, 2005, The role of inflammation in Alzheimer’s disease., Int. J. Biochem. Cell Biol., 37, 289, 10.1016/j.biocel.2004.07.009

Verkhratsky, 2010, Astrocytes in Alzheimer’s disease., Neurotherapeutics, 7, 399, 10.1016/j.nurt.2010.05.017

Wang, 2008, Chondroitin-4-sulfation negatively regulates axonal guidance and growth., J. Cell Sci., 121, 3083, 10.1242/jcs.032649

Wang, 2012, Alpha-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates beta-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation., Neuropharmacology, 62, 871, 10.1016/j.neuropharm.2011.09.016

Wu, 2016, Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer’s disease., Neuroscience, 333, 345, 10.1016/j.neuroscience.2016.07.038

Wyss-Coray, 2006, Inflammation in Alzheimer disease: driving force, bystander or beneficial response?, Nat. Med., 12, 1005

Yi, 2016a, Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathway., Neurosci. Lett., 624, 62, 10.1016/j.neulet.2016.05.004

Yi, 2016b, KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer’s disease., Mol. Cell Neurosci., 76, 21, 10.1016/j.mcn.2016.08.008

Yu, 2014, Targeted inhibition of KCa3.1 attenuates TGF-beta-induced reactive astrogliosis through the Smad2/3 signaling pathway., J. Neurochem., 130, 41, 10.1111/jnc.12710

Yu, 2013, Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation., Pharmacol. Res., 77, 30, 10.1016/j.phrs.2013.09.002